In this South African cohort of over 4000 treatment naive patients initiating first-line ART, we show that despite achieving viral suppression by six months post-initiation, poor CD4 count recovery was associated with increased risk of progression to new AIDS-defining condition and death over 24 months after viral suppression (events measured 6–30 months on ART). This evidence concerns the gene CD4 and AIDS.